April 1, 2026 · Form 4 insider transaction
Mukunda Ram bought 323,077 shares of IGC Pharma, Inc. at $0.26 per share, a transaction worth $84.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025.